Stockreport

Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression [Yahoo! Finance]

SciSparc Ltd.  (SPRC) 
PDF clinical-stage biotech company and a wholly-owned subsidiary of SciSparc Ltd. (Nasdaq: SPRC), today announced that Clearmind Medicine Inc. has filed an Israeli patent ap [Read more]